HLA‐A*24:02 increase the risk of allopurinol‐induced drug reaction with eosinophilia and systemic symptoms in HLA‐B*58:01 carriers in a Korean population; a multicenter cross‐sectional case‐control study-Reference-Cited by-同舟云学术

HLA‐A*24:02 increase the risk of allopurinol‐induced drug reaction with eosinophilia and systemic symptoms in HLA‐B*58:01 carriers in a Korean population; a multicenter cross‐sectional case‐control study

Published:2022-09 Issue:9 Volume:12 Page:
ISSN:2045-7022
Container-title:Clinical and Translational Allergy
language:en
Short-container-title:Clinical & Translational All

Author:

Kim Mi‐Yeong¹^ORCID,Yun James²,Kang Dong‐Yoon³^ORCID,Kim Tae Hee¹,Oh Min‐Kyung⁴,Lee Sunggun⁵,Kang Min‐Gyu⁶,Nam Young‐Hee⁷,Choi Jeong‐Hee⁸,Yang Min‐Suk⁹,Han Seung Seok¹⁰,Lee Hajeong¹⁰,Cho Hyun‐Jai¹⁰,Yang Jaeseok¹¹,Oh Kook‐Hwan¹⁰,Kim Yon Su¹⁰,Jung Jae Woo¹²,Lee Kye Hwa¹³^ORCID,Kang Hye‐Ryun³¹⁰¹⁴^ORCID

Affiliation:

1. Department of Internal Medicine Busan Paik Hospital Inje University College of Medicine Busan Korea

2. Department of Immunology and Rheumatology Nepean Hospital The University of Sydney Sydney Australia

3. Drug Safety Monitoring Center Seoul National University Hospital Seoul Korea

4. Department of Pharmacology Inje University College of Medicine Busan Korea

5. Department of Internal Medicine Haeundae Paik Hospital Inje University College of Medicine Busan Korea

6. Department of Internal Medicine Chungbuk National University Hospital Cheongju Korea

7. Department of Internal Medicine Dong‐A University College of Medicine Busan Korea

8. Department of Internal Medicine Hallym University Dongtan Sacred Heart Hospital Hallym University College of Medicine Hwaseong Korea

9. Department of Internal Medicine SMG‐SNU Boramae Medical Center Seoul Korea

10. Department of Internal Medicine Seoul National University College of Medicine Seoul Korea

11. Department of Internal Medicine Yonsei University College of Medicine Severance Hospital Seoul Korea

12. Department of Internal Medicine Chung‐Ang University College of Medicine Seoul Korea

13. Department of Information Medicine Asan Medical Center Seoul Korea

14. Institute of Allergy and Clinical Immunology Seoul National University Medical Research Center Seoul National University College of Medicine Seoul Korea

Publisher

Wiley

Subject

Immunology and Allergy,Immunology,Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/clt2.12193

Reference32 articles.

1. The Presence of HLA-B75, DR13 Homozygosity, or DR14 Additionally Increases the Risk of Allopurinol-Induced Severe Cutaneous Adverse Reactions in HLA-B*58:01 Carriers

2. Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging Urate-Lowering Drugs and Pharmacologic Treatment Strategies for Gout: A Narrative Review;Drugs;2023-10-11

2. Advances in understanding of the pathogenesis and therapeutic implications of drug reaction with eosinophilia and systemic symptoms: an updated review;Frontiers in Medicine;2023-06-29